Articles published by Elix, Inc.

Elix and LINC Become the First in the World to Commercialize an AI Drug Discovery Platform Incorporating Federated Learning-Based AI Models Trained on Data from 16 Pharmaceutical Companies

July 15, 2025

From Elix, Inc.

Via Business Wire

Elix and PRISM BioLab Join Forces to Accelerate AI-Driven Drug Discovery for Challenging Protein-Protein Interaction Targets

April 15, 2025

From Elix, Inc.

Via Business Wire

AI Drug Discovery Company Elix Commences Joint Research With Proprietary Screening Technology Holder SEEDSUPPLY

October 27, 2022

From Elix, Inc.

Via Business Wire

Elix Launches “Elix Discovery™,” the Only All-in-one Platform That Provides Everything Needed for AI Drug Discovery, from Models for Property Prediction and Molecular Design to AI Consulting and Implementation Support

July 14, 2022

From Elix, Inc.

Via Business Wire

Elix, Inc. Begins Collaboration With Shionogi & Co., Ltd. on Elix Synthesize™ (AI Drug Discovery Module) for Verification of Practical Retrosynthetic Analysis

March 24, 2022

From Elix, Inc.

Via Business Wire

kMoL, a Machine Learning Library for AI Drug Discovery With Federated Learning Capabilities

February 08, 2022

From Elix, Inc.

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.